Open AccessDirect comparison of dietary portfolio vs statin on C-reactive protein
Author(s) -
David Jenkins,
Cyril W.C. Kendall,
Augustine Marchie,
Dorothea Faulkner,
Andrea R. Josse,
Julia M W Wong,
Russell J. de Souza,
Azadeh Emam,
Tina Parker,
T J Li,
Robert G. Josse,
Lawrence A. Leiter,
William Singer,
Philip W. Connelly
Publication year - 2005
Publication title -
european journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 157
eISSN - 1476-5640
pISSN - 0954-3007
DOI - 10.1038/sj.ejcn.1602152
Subject(s) - medicine , statin , c reactive protein , endocrinology , cholesterol , biomarker , reductase , inflammation , chemistry , biochemistry , enzyme
3-Hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) markedly reduce serum cholesterol and have anti-inflammatory effects. The effect of cholesterol-lowering diets on inflammatory biomarkers is less well known.